About 700 reports

Pharmaceuticals and Healthcare PARTNER ##: DEPOMED, INC.

  • Cardiology
  • Neurology
  • Pharmaceutical
  • United States
  • Teva Pharmaceutical Industries Ltd.
  • Business description
  • PARTNERSHIP

PARTNER ##: H.

  • Immunology
  • Neurology
  • United States
  • M&A
  • Myriad Genetics, Inc.
  • Clinical Trial profile. 808 Trial Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Hormone
  • Neurological Disorder
  • Neurology
  • Shire plc
  • Target

Hoffmann-La Roche Ltd Emissary International LLC AegisCN LLC ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Abbott Laboratories ## ## ## ## ## Cinven Ltd ## ## ## ## ## BTG Plc Baxter International Inc AstraZeneca Plc Source: GlobalData

  • Clinical Trial
  • Neurology
  • Therapy
  • World
  • Pfizer Inc.

TARGET ##: KIRIN AGRIBIO CO., LTD.

  • Cancer
  • Healthcare
  • Neurology
  • Pharmaceutical
  • Kirin Group
  • Deal Report: Oncoceutics Enters into Research Agreement with National Institutes of Health

Deal in brief Partner ## Partner ## Partner ## Partner ## Deal status Deal category Deal sub-category Date of announcement National Institutes of Health National Institute of Neurological Disorders and Stroke U. S.

  • Healthcare
  • Neurology
  • Pharmaceutical
  • Therapy
  • Corporate Finance

This agreement enables Takeda Pharma and StrideBio to develop treatments for patients with neurological diseases.

  • Neurology
  • Pharmaceutical
  • World
  • Company
  • Deals & Alliance
  • MERGERS & ACQUISITIONS
  • PARTNERSHIP - DEAL REPORTS

Indevus has received an upfront payment of $## million from Cervelo.

  • Neurology
  • Pharmaceutical
  • United States
  • M&A
  • Endo International plc
  • PARTNERSHIP - DEAL REPORTS

PARTNER ##: PFIZER INC.

  • Healthcare
  • Neurology
  • Pharmaceutical
  • Therapy
  • Shire plc
  • Partner 3: Takeda Pharmaceuticals North America, Inc.

Company type Partner ##: enGene, Inc.

  • Healthcare
  • Neurology
  • Pharmaceutical
  • Therapy
  • Takeda Pharmaceutical Company Limited

The prominent features of this report are - ##.

  • Blood Supply
  • Clinical Trial
  • Neurology
  • World
  • Product Initiative

DEAL IN BRIEF Target ## Target ## Acquirer Seller/ Vendor ## Seller/ Vendor ## Seller/ Vendor ## Seller/ Vendor ## AES Laboratoire Groupe, S. A.

  • Neurology
  • France
  • Company
  • M&A
  • bioMerieux S.A.
  • Official Title
  • Official Title

The prominent features of this report are - ##.

  • Chemotherapy
  • Clinical Trial
  • Neurology
  • World
  • Product Initiative
  • Clinical Trial profile. 38 Trial Title
  • Clinical Trial profile. 36 Trial Title

Hoffmann-La Roche Ltd Bayer AG ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## AstraZeneca Plc Edge Therapeutics Inc D-Pharm Ltd Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are taken as of May 2017 ## ##

  • Clinical Trial
  • Drug Development
  • Neurology
  • World
  • Product Initiative
  • Official Title
  • Official Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Health Services
  • Neurology
  • World
  • Product Initiative

One Embarcadero Center, Suite ## J. P.

  • Healthcare
  • Neurology
  • Pharmaceutical
  • Therapy
  • Gilead Sciences, Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Neurology
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial profile. 582 Trial Title
  • Clinical Trial profile. 404 Trial Title

Freedman, Professor of Neurology, University of Ottawa.

  • Clinical Trial
  • Interferon
  • Neurological Disorder
  • Neurology
  • Biogen Idec Inc.
  • ADVISOR INFORMATION
  • Montreal

Completed ##. ## (min) Partnership Partner ## Partner ## Deal status Deal value (estimated) ($m) Deal category PARTNER ##: QUEST PHARMATECH, INC.

  • Neurology
  • Pharmaceutical
  • Canada
  • M&A
  • Paladin Labs Inc.
  • Clinical Trial profile. 252 Trial Title

Component ##.

  • Clinical Trial
  • Neurology
  • Opioid
  • World
  • Alkermes plc

Interest on notes will be paid semi annually March ## and September ## every year, commencing on September ##, 2018.

  • Neurology
  • Pharmaceutical
  • World
  • Company
  • Deals & Alliance
  • CLINICAL TRIAL PROFILE SNAPSHOTS

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Neurology
  • Pharmaceutical
  • World
  • Product Initiative
  • CSL Limited
  • Partner 2: Avigen Inc

GLASSIA [Alpha ##-Proteinase Inhibitor (Human)] is a liquid, ready-to-use treatment for alpha-## antitrypsin deficiency (AATD).

  • Cardiology
  • Healthcare
  • Neurology
  • Pharmaceutical
  • Baxter International Inc.

The prominent features of this report are - ##.

  • Neurology
  • Therapy
  • World
  • Product Initiative
  • Takeda Pharmaceutical Company Limited
  • FRED FLOW-DIVERTING STENT - PRODUCT DESCRIPTION
  • ADVANCED COIL - PRODUCT DESCRIPTION

WEB is braided from numerous wires, which in some cases are less than one-quarter of the diameter of a human hair.

  • Neurology
  • United States
  • Company
  • Product Initiative
  • MicroVention, Inc.
  • PARTNERSHIP - DEAL REPORTS
  • Deal in brief

Eva Feldman, M. D., Ph. D., the De Jong Professor of Neurology at the U-M Medical School.

  • Neurology
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Neuralstem, Inc.
  • Clinical Trial profile. 113 Trial Title
  • Clinical Trial profile. 107 Trial Title

GDCT ID IS THE UNIQUE ID OF GLOBALDATA' S PHARMA INTELLIGENCE CENTER CLINICAL TRIAL DATABASE Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Estimated

  • Hospital
  • Neurological Disorder
  • Neurology
  • World
  • Product Initiative

DEAL IN BRIEF Partner ## Partner ## Deal status Deal category Deal sub-category Date of completion Company type Stock exchange Ticker symbol Business description PARTNER ##: BIOLINERX LTD.

  • Neurology
  • Belgium
  • Company
  • M&A
  • Omega
  • PARTNERSHIP
  • TARGETS AND PARTNERS

Company type Business description PARTNER ##: NEURORECOVERY, INC.

  • Hospital
  • Neurology
  • United States
  • Company
  • Acorda Therapeutics, Inc.

RedHill will bear part of the drug' s development costs up to $## million.

  • Cardiology
  • Healthcare
  • Neurology
  • Pharmaceutical
  • IntelGenx Corp.